AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimzab MV 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Neucure Lifesciences Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimzab MV 2mg/500mg/0.3mg Tablet

Glimzab MV 2mg/500mg/0.3mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. This medication helps regulate blood glucose. Administer Glimzab MV with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continue this medication as prescribed, even if feeling well or experiencing controlled blood sugar; abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this is one element of a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption raises hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential; your doctor might also order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimzab MV 2mg/500mg/0.3mg Tablet

There is no text provided to rephrase.

Uses of Glimzab MV 2mg/500mg/0.3mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimzab MV 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Glimzab MV 2mg/500mg/0.3mg tablets on an empty stomach.

Common Side effects of Glimzab MV 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimzab MV 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Administer Glimzab MV 2mg/500mg/0.3mg Tablet on an empty stomach.

How Glimzab MV 2mg/500mg/0.3mg Tablet works:

Each Glimzab MV 2mg/500mg/0.3mg tablet contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimzab MV 2mg/500mg/0.3mg tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimzab MV 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimzab MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glimzab MV 2mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Glimzab MV 2mg/500mg/0.3mg Tablets is discouraged in those with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glimzab MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimzab MV 2mg/500mg/0.3mg Tablet :

Should you forget a Glimzab MV 2mg/500mg/0.3mg Tablet dose, ingest it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimzab MV 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimzab MV 2mg/500mg/0.3mg Tablet

Glimzab MV 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Glimzab MV 2mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, rash, and respiratory infection.
Glimzab MV 2mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimzab MV 2mg/500mg/0.3mg tablets and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glimzab MV 2mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimzab MV 2mg/500mg/0.3m...
125
MRP 145
13% off